T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
85 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Birmingham
Birmingham, Alabama, United States
- University of California San Francisco
San Francisco, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Midstate Medical Center
Meriden, Connecticut, United States
- Hartford Healthcare Cancer Institute at the Hospital of Central Connecticut
New Britain, Connecticut, United States
- William W Backus Hospital
Norwich, Connecticut, United States
- Georgetown Hospital
Washington D.C., District of Columbia, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Washington Cancer Institute at Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Florida Cancer Specialists
St. Petersburg, Florida, United States
- Mountain States Tumor Institute
Boise, Idaho, United States
- Mountain States Tumor Institute
Fruitland, Idaho, United States
- Mountain States Tumor Institute
Meridian, Idaho, United States
- Mountain States Tumor Institute
Nampa, Idaho, United States
- Mountain States Tumor Institute
Twin Falls, Idaho, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Chicago Comprehensive Cancer Center at Silver Cross Hospital
New Lenox, Illinois, United States
- University of Chicago Medical Center for Advanced Care Orland Park
Orland Park, Illinois, United States
- Indiana University - Springmill Medical Clinic
Indianapolis, Indiana, United States
- Indiana University - Wishard Hospital
Indianapolis, Indiana, United States
- Indiana University Health - Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Indiana University Health - University Hospital
Indianapolis, Indiana, United States
- Eastern Maine Medical Center'S Cancer Care
Brewer, Maine, United States
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Suburban Hospital Cancer Program
Bethesda, Maryland, United States
- Johns Hopkins - Green Spring Station
Lutherville, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Institute at Faulkner Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mass General North Shore Cancer Center
Danvers, Massachusetts, United States
- Lowell General Hospital
Lowell, Massachusetts, United States
- Dana-Farber Cancer Institute at Milford Hospital
Milford, Massachusetts, United States
- Univeristy of Michigan Health System
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Siteman Cancer Center - St. Peters
City of Saint Peters, Missouri, United States
- Barnes-Jewish Hospital
St Louis, Missouri, United States
- Siteman Cancer Center - South County
St Louis, Missouri, United States
- Siteman Cancer Center - West County
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 26 Aug 2019
- Completion
- 15 Jun 2022
- Last update posted
- 19 Feb 2026
- Registered enrollment
- 512
- Registry id
- NCT01853748
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.